---
title: "12 Health Care Stocks Moving In Thursday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286469293.md"
description: "In Thursday's after-market session, HCW Biologics saw a significant gain of 70.3%, reaching $0.57, following the release of Q1 earnings. Other notable gainers included P3 Health Partners (+47.14%), Alpha Cognition (+10.73%), and Shuttle Pharmaceuticals (+9.64%). Conversely, Dare Bioscience experienced the largest decline at 30.1%, with other losers including Aardvark Therapeutics (-15.16%) and Wellgistics Health (-10.11%). All companies reported Q1 earnings today, impacting their stock performance."
datetime: "2026-05-14T21:06:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286469293.md)
  - [en](https://longbridge.com/en/news/286469293.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286469293.md)
---

# 12 Health Care Stocks Moving In Thursday's After-Market Session

### Gainers

-   **HCW Biologics** (NASDAQ:HCWB) stock increased by 70.3% to $0.57 during Thursday's after-market session. The market value of their outstanding shares is at $2.3 million. As per the press release, Q1 earnings came out today.
-   **P3 Health Partners** (NASDAQ:PIII) stock moved upwards by 47.14% to $5.93. The market value of their outstanding shares is at $11.7 million. The company's, Q1 earnings came out today.
-   **Alpha Cognition** (NASDAQ:ACOG) stock rose 10.73% to $6.29. The company's market cap stands at $129.5 million. The company's, Q1 earnings came out today.
-   **Shuttle Pharmaceuticals** (NASDAQ:SHPH) stock moved upwards by 9.64% to $0.7. The market value of their outstanding shares is at $3.9 million.
-   **Voyager Therapeutics** (NASDAQ:VYGR) shares increased by 7.25% to $4.55. The market value of their outstanding shares is at $250.7 million.
-   **AVITA Medical** (NASDAQ:RCEL) stock increased by 7.11% to $4.67. The company's market cap stands at $131.1 million. As per the press release, Q1 earnings came out today.

### Losers

-   **Dare Bioscience** (NASDAQ:DARE) stock declined by 30.1% to $2.0 during Thursday's after-market session. The company's market cap stands at $41.3 million. As per the news, the Q1 earnings report came out today.
-   **Aardvark Therapeutics** (NASDAQ:AARD) stock declined by 15.16% to $5.71. The company's market cap stands at $143.7 million.
-   **Wellgistics Health** (NASDAQ:WGRX) stock decreased by 10.11% to $0.08. The company's market cap stands at $12.2 million.
-   **Zentek** (NASDAQ:ZTEK) shares declined by 10.0% to $0.9. The market value of their outstanding shares is at $108.6 million.
-   **Co-Diagnostics** (NASDAQ:CODX) shares decreased by 9.82% to $1.47. The company's market cap stands at $3.3 million. As per the news, the Q1 earnings report came out today.
-   **Akanda** (NASDAQ:AKAN) stock decreased by 9.04% to $22.65. The market value of their outstanding shares is at $12.9 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [DARE.US](https://longbridge.com/en/quote/DARE.US.md)
- [SHPH.US](https://longbridge.com/en/quote/SHPH.US.md)
- [WGRX.US](https://longbridge.com/en/quote/WGRX.US.md)
- [PIII.US](https://longbridge.com/en/quote/PIII.US.md)
- [ACOG.US](https://longbridge.com/en/quote/ACOG.US.md)
- [HCWB.US](https://longbridge.com/en/quote/HCWB.US.md)
- [VYGR.US](https://longbridge.com/en/quote/VYGR.US.md)
- [RCEL.US](https://longbridge.com/en/quote/RCEL.US.md)
- [AARD.US](https://longbridge.com/en/quote/AARD.US.md)
- [ZTEK.US](https://longbridge.com/en/quote/ZTEK.US.md)
- [CODX.US](https://longbridge.com/en/quote/CODX.US.md)
- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [PIIIW.US](https://longbridge.com/en/quote/PIIIW.US.md)

## Related News & Research

- [P3 Health Partners Q1 revenue rises 4%, adjusted EBITDA turns positive](https://longbridge.com/en/news/286461585.md)
- [HCW Biologics Q1 revenue surges on licensing deal](https://longbridge.com/en/news/286464528.md)
- [Wellgistics Health withdraws preliminary proxy as it evaluates strategic alternatives](https://longbridge.com/en/news/286762404.md)
- [Is Hims and Hers Health stock a buy after its latest dip?](https://longbridge.com/en/news/286450228.md)
- [Leerink Partners Reiterates "Market Perform" Rating for Regeneron Pharmaceuticals (NASDAQ:REGN)](https://longbridge.com/en/news/286773280.md)